Edit |   |
---|---|
Product Name | Trametinib |
Description | Trametinib is a small molecule which can act as a MEK inhibitor. It is provided as a white powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: Cytokine, Proliferation, PI3K, ERK. This product may be of interest in the following research areas and diseases: Cancer, Inflammation, Infectious disease. This product may act as a Coronavirus inhibitor: Limits ?cytokine storm? induced by SARS-CoV and MERS-CoV. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. Purity > 98% (TLC). Conforms to structure by NMR. MW: 615.4 g/mol |
Size | 10 mg, 50 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Trametinib, N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, GSK1120212, 871700-17-3 |
Gene, Accession, CAS # | CAS: 871700-17-3 |
Catalog # | abx283095 |
Price | please inquire |
Order / More Info | Trametinib from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950